https://www.selleckchem.com/pr....oducts/epalrestat.ht
Key clinical trial data for the currently available pharmacological options are presented to provide an overview of the efficacy and safety of these agents. To assess the performance of a fecal immunochemical test (FIT) among participants of a population-based colorectal cancer (CRC) screening program with one or more first-degree relatives (FDR) with CRC. Asymptomatic 50 to 74 years olds with a FDR diagnosed with CRC, enrolled in a colon screening program completed FIT (two samples, cut-off 20 µg Hemoglobin/gram feces) and underwent
Curtir
Comentario
Compartilhar
